Actively Recruiting
A Prospective Cohort Study of IgG4RD in China
Led by Peking Union Medical College Hospital · Updated on 2017-04-11
1000
Participants Needed
1
Research Sites
1043 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an cohort study to investigate the disease course and treatment response of patients with IgG4-related disease.
CONDITIONS
Official Title
A Prospective Cohort Study of IgG4RD in China
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males and females
- Age 18-75 years old with informed consent
- Patients with IgG4-RD showing swelling, sclerosing, and inflammatory involvement in one or more organs such as sclerosing pancreatitis, cholangitis, pseudotumors, fibrosis, nephritis, hypophysitis, dacryoadenitis, sialadenitis, aortic aneurysm, or lymphadenopathy
- Elevated serum IgG4 levels (>1.35 g/L)
- Histopathologic features of fibrosis and/or lymphocytic and polyclonal plasma cell infiltration, and IgG4+ plasma cells on immunohistology when performed
- Exclusion of other diseases
You will not qualify if you...
- Females planning to bear a child recently or with childbearing potential
- Concurrent severe, uncontrolled, or unstable diseases
- Patients with malignancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Deptment of Rheumatology, Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100032
Actively Recruiting
Research Team
H
Hua Chen, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here